Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Jounce Therapeutics, Inc. (JNCE)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K8-K10-K10-K
Revenues   [+]82.026.962.3147.965.270.171.637.2
            Revenue growth  204.8%-56.8%-57.8%126.8%-9.0% 92.6% 
Cost of goods sold  0.00.00.00.00.096.50.00.0
Gross profit  82.026.962.3147.965.2-26.471.637.2
            Gross margin  100.0%100.0%100.0%100.0%100.0%-37.7%100.0%100.0%
Selling, general and administrative   [+]31.029.028.827.926.426.423.116.8
Research and development  103.389.078.767.170.1 67.834.9
Other operating expenses       -21.6  
EBITDA   [+]-50.2-88.2-41.756.7-27.5 -14.8-12.5
            EBITDA margin  -61.2%-327.9%-66.9%38.3%-42.1%-44.7%-20.6%-33.7%
Depreciation and amortization  2.12.83.43.93.8 4.41.9
EBIT   [+]-52.2-91.1-45.152.8-31.3-31.3-19.2-14.5
            EBIT margin  -63.7%-338.4%-72.4%35.7%-48.0%-44.7%-26.8%-38.9%
Other income (expense), net  1.60.21.34.14.04.02.80.8
Pre-tax income  -50.6-90.8-43.856.9-27.3-27.3-16.4-13.7
Income taxes  0.10.00.00.00.00.00.00.0
            Tax rate     0.1%   0.0%
Net income  -50.8-90.9-43.856.9-27.3-27.4-17.2-23.1
            Net margin  -61.9%-337.7%-70.3%38.5%-41.9%-39.1%-24.1%-62.2%
   
Basic EPS   [+]($0.98)($1.82)($1.24)$1.72($0.84)($0.84)($0.57)($11.00)
Diluted EPS   [+]($0.98)($1.82)($1.24)$1.66($0.84)($0.84)($0.57)($11.00)
   
Shares outstanding (basic)   [+]51.749.935.433.132.632.630.12.1
Shares outstanding (diluted)   [+]51.749.935.434.332.632.630.12.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy